vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and DAWSON GEOPHYSICAL CO (DWSN). Click either name above to swap in a different company.

DAWSON GEOPHYSICAL CO is the larger business by last-quarter revenue ($26.9M vs $16.0M, roughly 1.7× CVRx, Inc.). DAWSON GEOPHYSICAL CO runs the higher net margin — 2.1% vs -74.5%, a 76.6% gap on every dollar of revenue. On growth, DAWSON GEOPHYSICAL CO posted the faster year-over-year revenue change (72.3% vs 4.4%). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs 5.4%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Dawson Geophysical Co is a North American geophysical services provider specializing in seismic data acquisition, processing and analysis. It primarily serves the oil and gas exploration and production sector, supporting clients to assess subsurface energy reserves across major onshore resource basins in the U.S. and Canada.

CVRX vs DWSN — Head-to-Head

Bigger by revenue
DWSN
DWSN
1.7× larger
DWSN
$26.9M
$16.0M
CVRX
Growing faster (revenue YoY)
DWSN
DWSN
+67.9% gap
DWSN
72.3%
4.4%
CVRX
Higher net margin
DWSN
DWSN
76.6% more per $
DWSN
2.1%
-74.5%
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
5.4%
DWSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVRX
CVRX
DWSN
DWSN
Revenue
$16.0M
$26.9M
Net Profit
$-11.9M
$569.0K
Gross Margin
86.3%
19.7%
Operating Margin
-69.8%
3.1%
Net Margin
-74.5%
2.1%
Revenue YoY
4.4%
72.3%
Net Profit YoY
-12.0%
170.9%
EPS (diluted)
$-0.45
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
DWSN
DWSN
Q4 25
$16.0M
$26.9M
Q3 25
$14.7M
$22.7M
Q2 25
$13.6M
$9.9M
Q1 25
$12.3M
$16.1M
Q4 24
$15.3M
$15.6M
Q3 24
$13.4M
Q2 24
$11.8M
$12.5M
Q1 24
$10.8M
$31.6M
Net Profit
CVRX
CVRX
DWSN
DWSN
Q4 25
$-11.9M
$569.0K
Q3 25
$-12.9M
$-1.2M
Q2 25
$-14.7M
$-2.3M
Q1 25
$-13.8M
$992.0K
Q4 24
$-10.7M
$-802.0K
Q3 24
$-13.1M
Q2 24
$-14.0M
$-3.5M
Q1 24
$-22.2M
$5.8M
Gross Margin
CVRX
CVRX
DWSN
DWSN
Q4 25
86.3%
19.7%
Q3 25
86.8%
10.1%
Q2 25
84.3%
11.5%
Q1 25
83.5%
26.7%
Q4 24
83.2%
19.9%
Q3 24
83.2%
Q2 24
83.9%
1.0%
Q1 24
85.0%
30.5%
Operating Margin
CVRX
CVRX
DWSN
DWSN
Q4 25
-69.8%
3.1%
Q3 25
-83.5%
-5.2%
Q2 25
-105.8%
-24.1%
Q1 25
-108.8%
6.4%
Q4 24
-67.0%
-5.3%
Q3 24
-97.3%
Q2 24
-118.3%
-30.1%
Q1 24
-206.4%
18.4%
Net Margin
CVRX
CVRX
DWSN
DWSN
Q4 25
-74.5%
2.1%
Q3 25
-87.6%
-5.1%
Q2 25
-108.4%
-23.8%
Q1 25
-111.5%
6.2%
Q4 24
-69.4%
-5.1%
Q3 24
-98.0%
Q2 24
-118.8%
-28.3%
Q1 24
-206.0%
18.5%
EPS (diluted)
CVRX
CVRX
DWSN
DWSN
Q4 25
$-0.45
$0.03
Q3 25
$-0.49
$-0.04
Q2 25
$-0.57
$-0.08
Q1 25
$-0.53
$0.03
Q4 24
$-0.39
$-0.02
Q3 24
$-0.57
Q2 24
$-0.65
$-0.12
Q1 24
$-1.04
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
DWSN
DWSN
Cash + ST InvestmentsLiquidity on hand
$75.7M
$5.3M
Total DebtLower is stronger
$11.3M
Stockholders' EquityBook value
$39.3M
$15.8M
Total Assets
$104.8M
$56.0M
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
DWSN
DWSN
Q4 25
$75.7M
$5.3M
Q3 25
$85.1M
$5.1M
Q2 25
$95.0M
$16.2M
Q1 25
$102.7M
$2.7M
Q4 24
$105.9M
$1.4M
Q3 24
$100.2M
Q2 24
$70.4M
$11.4M
Q1 24
$80.1M
$11.7M
Total Debt
CVRX
CVRX
DWSN
DWSN
Q4 25
$11.3M
Q3 25
$6.5M
Q2 25
$1.1M
Q1 25
$1.3M
Q4 24
$1.5M
Q3 24
Q2 24
$1.4M
Q1 24
$1.5M
Stockholders' Equity
CVRX
CVRX
DWSN
DWSN
Q4 25
$39.3M
$15.8M
Q3 25
$48.1M
$15.2M
Q2 25
$57.9M
$16.4M
Q1 25
$71.1M
$18.3M
Q4 24
$71.1M
$17.3M
Q3 24
$65.2M
Q2 24
$55.2M
$23.8M
Q1 24
$66.3M
$27.3M
Total Assets
CVRX
CVRX
DWSN
DWSN
Q4 25
$104.8M
$56.0M
Q3 25
$111.3M
$40.6M
Q2 25
$119.6M
$45.7M
Q1 25
$129.6M
$33.3M
Q4 24
$133.4M
$30.9M
Q3 24
$127.7M
Q2 24
$96.0M
$41.0M
Q1 24
$106.2M
$57.8M
Debt / Equity
CVRX
CVRX
DWSN
DWSN
Q4 25
0.72×
Q3 25
0.43×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.09×
Q3 24
Q2 24
0.06×
Q1 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
DWSN
DWSN
Operating Cash FlowLast quarter
$-9.8M
$2.1M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
3.67×
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
DWSN
DWSN
Q4 25
$-9.8M
$2.1M
Q3 25
$-9.7M
$-4.7M
Q2 25
$-7.9M
$14.9M
Q1 25
$-12.8M
$1.8M
Q4 24
$-8.0M
$-5.4M
Q3 24
$-10.4M
Q2 24
$-9.8M
$5.9M
Q1 24
$-10.9M
$1.9M
Free Cash Flow
CVRX
CVRX
DWSN
DWSN
Q4 25
$-9.8M
Q3 25
$-10.0M
$-10.2M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
$-5.7M
Q3 24
$-10.4M
Q2 24
$-10.2M
$5.1M
Q1 24
$-11.8M
$1.2M
FCF Margin
CVRX
CVRX
DWSN
DWSN
Q4 25
-61.3%
Q3 25
-68.1%
-44.7%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
-36.7%
Q3 24
-78.1%
Q2 24
-86.3%
40.9%
Q1 24
-109.7%
3.8%
Capex Intensity
CVRX
CVRX
DWSN
DWSN
Q4 25
0.4%
Q3 25
2.0%
23.9%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
2.0%
Q3 24
0.3%
Q2 24
3.0%
6.4%
Q1 24
8.5%
2.2%
Cash Conversion
CVRX
CVRX
DWSN
DWSN
Q4 25
3.67×
Q3 25
Q2 25
Q1 25
1.77×
Q4 24
Q3 24
Q2 24
Q1 24
0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

DWSN
DWSN

Fee Revenue$22.9M85%
Other$4.0M15%

Related Comparisons